Inter Partes Review Of Patented Anti-Diabetic Medication Requested
ALEXANDRIA, Va. — A patent used in three Novo Nordisk A/S diabetes drugs would have been obvious to a person of skill in the art (POSA), a petitioner for inter partes...To view the full article, register now.
Already a subscriber? Click here to view full article